Otonomy (OTIC) – Corporate News
-
NASDAQ Announces Delisting of Securities of Tuscan Holdings Corp. II; Clovis Oncology, Inc.; ZyVersa Therapeutics, Inc.; Otonomy, Inc., and Forward Pharma A/S
-
Otonomy (OTIC) Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to OTIC Stock Lookup